Beauty Health Company (The) EBIT

Beauty Health Company (The) (SKIN) currently reports a EBIT of $-220M as of September 2021. That is below the Healthcare sector average of $22B. Use the charts on this page to explore Beauty Health Company (The)'s EBIT history and peer comparisons.

Beauty Health Company (The)'s EBIT of $-220M is lower than the Healthcare sector average of $22B. That is roughly 101.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Beauty Health Company (The) reported $-220M in EBIT as of September 2021. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-220M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $22B. From there, open related valuation or income-statement pages for Beauty Health Company (The), and consider following SKIN for alerts when major investors trade the stock.

Beauty Health Company (The) is classified in the Healthcare sector. On EBIT, it currently shows $-220M versus a sector average near $22B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SKIN with unrelated industries.